Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Neurona Therapeutics
Biotech
UCB strikes $1.15B deal for cell therapy biotech Neurona
Besides building UCB's epilepsy position, the deal "marks a strategic expansion into regenerative medicine and advanced therapies," the company said.
Eric Sagonowsky
Apr 17, 2026 1:55pm
Gilead abruptly parts ways with general counsel—Chutes & Ladders
Nov 21, 2025 8:30am
Cell therapy biotech bags $102M to fund phase 3 epilepsy plans
Apr 3, 2025 1:22pm
Neurona knocks out $120M raise a year after layoffs
Feb 8, 2024 8:00am
Neurona cites difficult funding environment for staff cuts
Feb 6, 2023 1:58pm
